within Pharmacolibrary.Drugs.ATC.G;

model G03DB07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 10 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Promegestone is a synthetic progestin, structurally related to progesterone, used primarily as a component of menopausal hormone therapy, as well as in gynecological disorders such as endometriosis and menstrual problems. It was introduced in Europe but is not widely approved or used today outside a few countries.</p><h4>Pharmacokinetics</h4><p>No published peer-reviewed pharmacokinetic models with explicit compartmental parameters found for promegestone in humans. Parameters below are estimates based on typical values for orally administered progestins of similar structure in healthy adult women.</p><h4>References</h4><ol><li><p>Bray, JD, et al., &amp; Lyttle, CR (2005). Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. <i>The Journal of steroid biochemistry and molecular biology</i> 97(4) 328–341. DOI:<a href=&quot;https://doi.org/10.1016/j.jsbmb.2005.06.032&quot;>10.1016/j.jsbmb.2005.06.032</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16157482/&quot;>https://pubmed.ncbi.nlm.nih.gov/16157482</a></p></li><li><p>Attardi, BJ, et al., &amp; Reel, JR (2006). Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity. <i>Endocrinology</i> 147(6) 3016–3026. DOI:<a href=&quot;https://doi.org/10.1210/en.2005-1524&quot;>10.1210/en.2005-1524</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16497801/&quot;>https://pubmed.ncbi.nlm.nih.gov/16497801</a></p></li><li><p>Pettersen, PC, et al., &amp; Christiansen, C (2008). Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms. <i>Climacteric : the journal of the International Menopause Society</i> 11(2) 135–143. DOI:<a href=&quot;https://doi.org/10.1080/13697130801930385&quot;>10.1080/13697130801930385</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18365856/&quot;>https://pubmed.ncbi.nlm.nih.gov/18365856</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03DB07;
